MustGrow Biologics logo

MustGrow Biologics(TSXV) MGRO

Market CapCA$29.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+27%
5 Year-89%
1 Year-40%
1 Month+2%
CA$0.42
+3.70%
+0.02Today
MustGrow Biologics last closing stock price
MetricPriceDate
Last closeCAD 0.422026-10-15
MustGrow Biologics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.45%CAD 0.442026-10-08
1 month+2.44%CAD 0.412026-09-15
3 month+20%CAD 0.352026-07-17
Year to date-33.33%CAD 0.632025-12-31
1 year-40%CAD 0.702025-10-15
3 year-65%CAD 1.202023-10-16
5 year-89.37%CAD 3.952021-10-15
Since inception+26.56%CAD 0.322019-07-10

MustGrow Biologics Financials at a Glance

Market Cap

CA$29.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$3.19M

Net Income (TTM)

-CA$5.57M

EPS (TTM)

-CA$0.10

P/E Ratio

-4.33

Dividend

CA$0.00

Beta (Volatility)

0.50 (Low)

Price

CA$0.42

Volume

26,813

Open

CA$0.45

Previous Close

CA$0.42

Daily Range

CA$0.39 - CA$0.45

52-Week Range

CA$0.29 - CA$0.94

Estimated Earnings Date

Dec 1, 2026

MGRO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MustGrow Biologics

MustGrow Biologics Corp. is an agricultural biotechnology company focused on developing and commercializing natural crop protection solutions derived from mustard seed. The company specializes in biopesticides, biofumigants, and bioherbicides, aiming to enhance agricultural productivity while promoting sustainable practices.

Products and Services
  • Biopesticides for effective pest management
  • Biofumigants to combat soil-borne diseases
  • Post-harvest treatments to extend shelf life of produce
Growth Outlook
  • Recent quarterly revenue reached CAD 1,438,199, a significant increase
  • Gross profit margin improved to 94.68% in Q2 2026
  • Strong cash position with CAD 4,374,012 in cash and equivalents
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 2,000,000
  • Current ratio of 3.63 indicates strong liquidity
  • Net income of CAD 284,695 in Q2 2026, a positive trend
MustGrow Biologics Corp. is positioned in the agricultural inputs sector, focusing on innovative solutions that align with the growing demand for sustainable farming practices. The company's unique offerings, derived from mustard seed, provide effective alternatives to traditional chemical pesticides, appealing to both organic and conventional farmers. The recent financial performance indicates a positive trajectory, with significant revenue growth and improved profitability metrics. The strong cash position further supports ongoing research and development efforts, positioning the company for future expansion in the agricultural biotechnology market.
AI Generated • Oct 9, 2026

Industry

Chemicals

Sector

Materials

Employees

8

CEO

Corey J. Giasson, MBA

Website

www.mustgrow.ca

Headquarters

Saskatoon, SK S7K 1J5, CA

MGRO Financials

Key Financial Metrics (TTM)

Gross Margin

52.78%

Operating Margin

-132.57%

Net Income Margin

-174.40%

Return on Equity

-218.75%

Return on Capital

-430.85%

Return on Assets

-77.72%

Earnings Yield

-23.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$29.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

70.44M

Volume

26.81K

Avg. Volume

39.36K

Financials (TTM)

Gross Profit

CA$1.68M

Operating Income

-CA$4.23M

EBITDA

-CA$4.20M

Operating Cash Flow

-CA$2.85M

Capital Expenditure

-CA$1.49M

Free Cash Flow

-CA$4.34M

Cash & ST Invst.

CA$4.37M

Total Debt

CA$515.57K

MustGrow Biologics Performance Analysis

MustGrow Biologics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 6,479-49.7%
20232023-12-31CAD 4,712,20072630.4%
20242024-12-31CAD 398,018-91.6%
20252025-12-31CAD 8,286,5411982.0%
MustGrow Biologics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-72.3%
Q42025-12-319.8%
Q12026-03-31-88.7%
Q22026-06-301364.8%
MustGrow Biologics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.1162.3%
20232023-12-31CAD -0.01-88.0%
20242024-12-31CAD -0.09597.1%
20252025-12-31CAD -0.1340.8%
MustGrow Biologics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-112.4%
Q42025-12-3119.6%
Q12026-03-3140.1%
Q22026-06-30121.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$1.44M

-49.5%

Gross Profit

CA$1.36M

+129.0%

Gross Margin

94.68%

N/A

Market Cap

CA$29.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$3.70M

N/A

Employees

8

N/A

Net Income

CA$284.70K

+126.1%

EBITDA

CA$429.86K

+142.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$4.37M

+140.2%

Total Debt

CA$515.57K

-83.6%

Accounts Receivable

CA$1.44M

+60.1%

Inventory

CA$566.83K

-69.2%

Long Term Debt

CA$138.51K

-94.7%

Short Term Debt

CA$377.06K

-29.1%

Return on Assets

-77.72%

N/A

Return on Invested Capital

-81.56%

N/A

Free Cash Flow

CA$613.26K

+281.5%

Operating Cash Flow

CA$613.26K

+287.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NPR.VNorth Peak Resources Ltd.
CA$0.62-1.59%
MRZ.VMirasol Resources Ltd.
CA$0.31+0.00%
SAM.TOStarcore International Mines Ltd.
CA$0.32+1.59%
AAN.VAton Resources Inc.
CA$0.39+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.63-0.13%
INTCIntel
$95.37-2.80%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$107.35-2.89%
CRWVCoreWeave
$69.69+5.94%

Questions About MGRO

What is the current price of MustGrow Biologics?

MustGrow Biologics is trading at CA$0.42 per share.

What is the 52-week range for MustGrow Biologics?

Over the past 52 weeks, MustGrow Biologics has traded between CA$0.29 and CA$0.94.

How much debt does MustGrow Biologics have?

As of the most recent reporting period, MustGrow Biologics reported total debt of CA$515.57K.

How much cash does MustGrow Biologics have on hand?

MustGrow Biologics reported CA$4.37M in cash and cash equivalents in its most recent financial results.

What is MustGrow Biologics’s dividend yield?

MustGrow Biologics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services